1
|
Shieh Y, Swartz AR, Rustandi RR. Detection of residual T7 RNA polymerase used in mRNA in vitro transcription by Simple Western. Electrophoresis 2024. [PMID: 38899564 DOI: 10.1002/elps.202400044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2024] [Revised: 05/03/2024] [Accepted: 05/28/2024] [Indexed: 06/21/2024]
Abstract
Therapeutic messenger RNA (mRNA) has been demonstrated as a scalable and versatile vaccine platform for the rapid development and manufacture of new vaccine candidates. mRNA is synthesized enzymatically through in vitro transcription (IVT) using bacteriophage T7 RNA polymerase (T7 RNAP), a 99 kDa protein with high binding affinity for the promoter sequence and a low error rate. Post-IVT, mRNA is purified to remove impurities, but if T7 RNAP is insufficiently cleared, undesirable clinical side effects may result. Therefore, it is important to quantitate T7 RNAP concentrations in IVT and process intermediates to understand clearance during downstream purification. A high-throughput T7 RNAP assay was developed using Simple Western (SW), a capillary immunoassay technology, to quantitate concentrations as low as 5.3 ng/mL with good precision and accuracy. Compared to existing T7 RNAP immunoassays or total protein assays such as bicinchoninic acid assays or Bradford, the SW T7 RNAP assay is specific to T7 RNAP, requires <10 µL of sample volume, and consists of minimal sample handling and hands-on time. This work highlights the development and optimization of a highly sensitive and robust T7 RNAP quantitation assay using the SW platform.
Collapse
Affiliation(s)
- Yvonne Shieh
- Analytical Research Development Merck & Co. Inc, Rahway, New Jersey, USA
| | - Andrew R Swartz
- Process Research & Development Merck & Co. Inc., Rahway, New Jersey, USA
| | - Richard R Rustandi
- Analytical Research Development Merck & Co. Inc, Rahway, New Jersey, USA
| |
Collapse
|
2
|
Deiss A, Loughney JW, Rustandi RR, Vuolo K, Mackey MA. Development and qualification of an automated capillary Western method for the identification of polysaccharide serotypes in pneumococcal conjugate vaccine (PCV). J Pharm Biomed Anal 2024; 238:115788. [PMID: 37866079 DOI: 10.1016/j.jpba.2023.115788] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2023] [Revised: 10/02/2023] [Accepted: 10/10/2023] [Indexed: 10/24/2023]
Abstract
Streptococcus pneumoniae bacterial infection causes mortality in both adults and infants. To mitigate the impact of the disease, several Pneumococcal conjugate vaccines (PCVs) have been manufactured for the U.S. market, including the recent approval of the 15-valent PCV Vaxneuvance™ from MSD. These vaccines demonstrate high efficacy for both the adult and pediatric dose. These PCVs contain multiple unique serotypes in the final, formulated vaccine product, and identifying a specific polysaccharide, in the presence of other serotypes, is a critical quality attribute that must be demonstrated through analytical testing. Here we describe the development and qualification of an identity assay using an automated capillary western system, called Simple Western, implementing a multi-valent system suitability sample (SSS) to determine individual polysaccharide components. The assay was optimized through rigorous analytical development and was successfully qualified for use in the clinical release of the PCV.
Collapse
Affiliation(s)
- Alyssa Deiss
- Analytical Research Development, Merck & Co., Inc., Rahway, NJ, USA.
| | - John W Loughney
- Analytical Research Development, Merck & Co., Inc., Rahway, NJ, USA
| | | | - Kimberly Vuolo
- Analytical Research Development, Merck & Co., Inc., Rahway, NJ, USA
| | - Megan A Mackey
- Analytical Research Development, Merck & Co., Inc., Rahway, NJ, USA
| |
Collapse
|
3
|
Pearson C, Wang Y, Alkurdi E, Zhang Y, Yin K, Rustandi RR, Loughney JW. Quantitation of host cell proteins in biopharmaceuticals from chinese hamster ovarian and vero cell lines using capillary electrophoresis western blots. J Pharm Biomed Anal 2023; 233:115420. [PMID: 37207489 DOI: 10.1016/j.jpba.2023.115420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2023] [Revised: 04/12/2023] [Accepted: 04/24/2023] [Indexed: 05/21/2023]
Abstract
Quantitation of host cell proteins (HCPs) is essential in the process of preparation of many biological and vaccine products. Common methods of quantitation include the widely applied enzyme-linked immunosorbent assays (ELISAs), mass spectrometry (MS) and other orthogonal assays. Prior to using these techniques, critical reagents need to be evaluated, for example, antibodies need to be assessed for HCP coverage. Percent of HCP coverage is often established by denatured 2D Western blot. However, ELISAs measure the amount of HCP only in a native state. There are limited studies linking reagents validated by 2D-Western to ensure adequate coverage in the final ELISA. ProteinSimple's newly developed capillary Western blot technology allows for separation, blotting, and detection of proteins in a semi-automated and simplified format. Capillary Westerns are similar to slab Westerns, with the added benefit of being quantitative. Here we outline the capillary Western method that links the 2D Western coverage and ultimately ELISAs for more efficient HCP quantitation. This study describes the development of the capillary Western analytical method to quantitively evaluate HCPs in Vero and Chinese Hamster Ovarian (CHO) cell lines. The amount of CHO HCPs decreases as the sample is purified as expected. Using this approach, we determined that the detected Vero HCPs amount was similar irrespective of denatured (capillary Western) versus native assay format (ELISA). This new method can also be potentially employed to quantitatively assess the anti-HCP antibody reagent coverage used in commercial HCP ELISA kits.
Collapse
Affiliation(s)
- Cara Pearson
- Analytical Research & Development Merck & Co., Inc., Rahway, NJ, USA
| | - Yi Wang
- Analytical Research & Development Merck & Co., Inc., Rahway, NJ, USA
| | - Eman Alkurdi
- Analytical Research & Development Merck & Co., Inc., Rahway, NJ, USA
| | - Young Zhang
- Analytical Research & Development Merck & Co., Inc., Rahway, NJ, USA
| | - Kuo Yin
- Analytical Research & Development Merck & Co., Inc., Rahway, NJ, USA
| | | | - John W Loughney
- Analytical Research & Development Merck & Co., Inc., Rahway, NJ, USA.
| |
Collapse
|
4
|
Gillespie PF, Wang Y, Hofmann C, Kuczynski LE, Winters MA, Teyral JL, Tubbs CM, Shiflett K, Patel N, Rustandi RR. Understanding the Spike Protein in COVID-19 Vaccine in Recombinant Vesicular Stomatitis Virus (rVSV) Using Automated Capillary Western Blots. ACS OMEGA 2023; 8:3319-3328. [PMID: 36685032 PMCID: PMC9843631 DOI: 10.1021/acsomega.2c06937] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/27/2022] [Accepted: 12/14/2022] [Indexed: 06/17/2023]
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the viral agent that is responsible for the coronavirus disease-2019 (COVID-19) pandemic. One of the live virus vaccine candidates Merck and Co., Inc. was developing to help combat the pandemic was V590. V590 was a live-attenuated, replication-competent, recombinant vesicular stomatitis virus (rVSV) in which the envelope VSV glycoprotein (G protein) gene was replaced with the gene for the SARS-CoV-2 spike protein (S protein), the protein responsible for viral binding and fusion to the cell membrane. To assist with product and process development, a quantitative Simple Western (SW) assay was successfully developed and phase-appropriately qualified to quantitate the concentration of S protein expressed in V590 samples. A strong correlation was established between potency and S-protein concentration, which suggested that the S-protein SW assay could be used as a proxy for virus productivity optimization with faster data turnaround time (3 h vs 3 days). In addition, unlike potency, the SW assay was able to provide a qualitative profile assessment of the forms of S protein (S protein, S1 subunit, and S multimer) to ensure appropriate levels of S protein were maintained throughout process and product development. Finally, V590 stressed stability studies suggested that time and temperature contributed to the instability of S protein demonstrated by cleavage into its subunits, S1 and S2, and aggregation into S multimer. Both of which could potentially have a deleterious effect on the vaccine immunogenicity.
Collapse
Affiliation(s)
- Paul F. Gillespie
- Analytical
Research Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania19486, United States
| | - Yanjie Wang
- Analytical
Research Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania19486, United States
| | - Carl Hofmann
- Analytical
Research Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania19486, United States
| | - Laura E. Kuczynski
- Vaccine
Process Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania19486, United States
| | - Michael A. Winters
- Vaccine
Process Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania19486, United States
| | - Jennifer L. Teyral
- Research
CMC Statistics, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania19486, United States
| | - Christopher M. Tubbs
- Analytical
Research Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania19486, United States
| | - Kelsey Shiflett
- Analytical
Research Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania19486, United States
| | - Nisarg Patel
- Analytical
Research Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania19486, United States
| | - Richard R. Rustandi
- Analytical
Research Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania19486, United States
| |
Collapse
|
5
|
Gillespie PF, Rustandi RR, Swartz AR, Shang L, Raffaele J, Prout A, Cunningham N, Dawod M, Deng JZ, Wang S, Olson J, Shieh Y, Loughney JW. Quantitation of Coxsackievirus A21 Viral Proteins in Mixtures of Empty and Full Capsids Using Capillary Western. Hum Gene Ther 2023; 34:68-77. [PMID: 36503264 DOI: 10.1089/hum.2022.147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
A prototype strain of Coxsackievirus A21 (CVA21) is being evaluated as an oncolytic virus immunotherapy. CVA21 preferentially lyses cells that upregulate the expression of intercellular adhesion molecule 1, which includes some types of tumor cells. CVA21 has an icosahedral capsid structure made up of 60 protein subunits encapsidating a viral RNA genome with a particle diameter size of 30 nm. Rapid and robust analytical methods to quantify CVA21 total, empty, and full virus particles are important to support the process development, meet regulatory requirements, and validate manufacturing processes. In this study, we demonstrate the detection of all four CVA21 capsid proteins, VP1, VP2, VP3, and VP4, as well as VP0, a surrogate for empty particles, using in-house-generated antibodies. An automated and quantitative capillary Western blot assay, Simple Western, was developed using these antibodies to quantify CVA21 total particles through VP1, empty particles through VP0, relative ratio of empty to full particles through VP0 and VP4, and the absolute ratio of empty to total particles through VP0 and VP1. Finally, this Simple Western method was used to support CVA21 cell culture and purification process optimization as a high-throughput analytical tool to make rapid process decisions.
Collapse
Affiliation(s)
| | | | - Andrew R Swartz
- Vaccine Process Research and Development, Merck & Co., Inc., Rahway, New Jersey, USA
| | | | | | | | | | | | | | | | - Jessica Olson
- Vaccine Process Research and Development, Merck & Co., Inc., Rahway, New Jersey, USA
| | - Yvonne Shieh
- Vaccine Process Research and Development, Merck & Co., Inc., Rahway, New Jersey, USA
| | | |
Collapse
|
6
|
30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization. Vaccines (Basel) 2022; 10:vaccines10111964. [DOI: 10.3390/vaccines10111964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2022] [Revised: 11/15/2022] [Accepted: 11/17/2022] [Indexed: 11/22/2022] Open
Abstract
Pneumonia accounts for over 20% of deaths worldwide in children aged 1 to 5 years, disproportionately affecting lower- and middle-income countries. Effective, highly multivalent pneumococcal vaccines are available to decrease disease burden, with numerous new vaccines currently under development to serve a variety of worldwide markets. However, pneumococcal conjugate vaccines are among the hardest biologics to manufacture and characterize due to their complexity and heterogeneity. Current characterization methods are often inherently singleplex, requiring separate tests for each serotype present. In addition, identity and quantity are often determined with separate methods. We developed the VaxArray pneumococcal assay for applications in identity, quantity, and stability testing of pneumococcal polysaccharide and pneumococcal conjugate vaccines. The VaxArray pneumococcal assay has a time to result of less than 30 min and is an off-the-shelf multiplexed, microarray-based immunoassay kit that can identify and simultaneously quantify 23 pneumococcal polysaccharide serotypes common to many on-market and in-development vaccines. Here, we highlight the potential of the assay for identity testing by showing high reactivity and serotype specificity to a wide variety of native polysaccharides, CRM197-conjugated polysaccharides, and drug product. The assay also has vaccine-relevant lower limits of quantification in the low-to-mid ng/mL range and can be used for accurate quantification even in adjuvanted vaccines. Excellent correlation to the anthrone assay is demonstrated, with VaxArray resulting in significantly improved precision over this antiquated chemical method.
Collapse
|
7
|
Analytical technology development to monitor the stability of Polysaccharide-Protein conjugate vaccines. Vaccine 2022; 40:4182-4189. [PMID: 35688729 DOI: 10.1016/j.vaccine.2022.05.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2022] [Revised: 05/11/2022] [Accepted: 05/20/2022] [Indexed: 11/22/2022]
Abstract
The covalent attachment of a bacterial-derived capsular polysaccharide to protein is of critical importance in transforming the polysaccharide from an antigen with limited immunogenicity in infants and older adults to an antigen that can prevent potentially fatal disease. For a polysaccharide-protein conjugate vaccine (PCV) candidate to be successful, it must be sufficiently stable. Chemical breakage of carbohydrate bonds in the polysaccharide may result in the reduction of "conjugate dose" and could negatively impact immunogenicity and the ability of the vaccine to prime for memory responses. Therefore, development of analytical tools to monitor the integrity of a polysaccharide-protein conjugate (glycoconjugate) vaccine is of practical significance. In this work, reducing SDS-PAGE, Intrinsic Protein Fluorescence Spectroscopy (IPFS), Differential Scanning Fluorimetry (DSF) were evaluated methods to study the impact of time, temperature, and formulation composition on the stability of a glycoconjugate vaccine prepared by multisite coupling of polysaccharide to a carrier protein. In addition, an automated capillary Western system was also evaluated to study the impact of storage on glycoconjugate vaccine stability. Two streptococcus pneumoniae polysaccharide-protein conjugates (serotype 3 and serotype 19A) were chosen to examine their physicochemical stability when formulated as a single antigen vaccine. While all methods require only a small amount of test article and can test multiple samples per assay run, automated capillary Western has the additional advantage of being highly sensitive even at low concentrations in complex vaccine formulations that contain aluminum adjuvant and multiple antigens. Results suggest that automated capillary Western is stability-indicating and may be an effective analytical technology tool for the formulation development of a multivalent glycoconjugate vaccine.
Collapse
|
8
|
Singh KK, Gupta A, Bharti C, Sharma H. Emerging techniques of western blotting for purification and analysis of protein. FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES 2021. [DOI: 10.1186/s43094-021-00386-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Abstract
Background
Western blotting is frequently employed in molecular techniques like Proteomics and Biology. Because it is a sequential framework, differences and inaccuracies could even take place at any stage, decreasing this particular method's reproducibility and reliability.
Main text
New approaches, like automated microfluid western blotting, DigiWest, single cell resolution, microchip electrophoresis, and capillary electrophoresis, were all implemented to reduce the future conflicts linked with the western blot analysis approach. Discovery of new in devices and higher susceptibility for western blots gives innovative opportunities to expand Western blot’s clinical relevance. The advancements in various region of west blotting included in this analysis of transfer of protein and validation of antibody are described.
Conclusion
This paper describes another very developed strategy available as well as demonstrated the correlation among Western blotting techniques of the next generation and their clinical implications. In this review, the different techniques of western blotting and their improvement in different stages have been discussed.
Collapse
|
9
|
Geurink L, van Tricht E, van der Burg D, Scheppink G, Pajic B, Dudink J, Sänger-van de Griend C. Sixteen capillary electrophoresis applications for viral vaccine analysis. Electrophoresis 2021; 43:1068-1090. [PMID: 34739151 DOI: 10.1002/elps.202100269] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2021] [Revised: 10/14/2021] [Accepted: 10/25/2021] [Indexed: 12/14/2022]
Abstract
A broad range of CE applications from our organization is reviewed to give a flavor of the use of CE within the field of vaccine analyses. Applicability of CE for viral vaccine characterization, and release and stability testing of seasonal influenza virosomal vaccines, universal subunit influenza vaccines, Sabin inactivated polio vaccines (sIPV), and adenovirus vector vaccines were demonstrated. Diverse CZE, CE-SDS, CGE, and cIEF methods were developed, validated, and applied for virus, protein, posttranslational modifications, DNA, and excipient concentration determinations, as well as for the integrity and composition verifications, and identity testing (e.g., CZE for intact virus particles, CE-SDS application for hemagglutinin quantification and influenza strain identification, chloride or bromide determination in process samples). Results were supported by other methods such as RP-HPLC, dynamic light scattering (DLS), and zeta potential measurements. Overall, 16 CE methods are presented that were developed and applied, comprising six adenovirus methods, five viral protein methods, and methods for antibodies determination of glycans, host cell-DNA, excipient chloride, and process impurity bromide. These methods were applied to support in-process control, release, stability, process- and product characterization and development, and critical reagent testing. Thirteen methods were validated. Intact virus particles were analyzed at concentrations as low as 0.8 pmol/L. Overall, CE took viral vaccine testing beyond what was previously possible, improved process and product understanding, and, in total, safety, efficacy, and quality.
Collapse
Affiliation(s)
- Lars Geurink
- Janssen Vaccines and Prevention B.V., CN Leiden, The Netherlands.,Department of Medicinal Chemistry, Faculty of Pharmacy, Biomedical Centre, Uppsala University, Uppsala, Sweden
| | - Ewoud van Tricht
- Janssen Vaccines and Prevention B.V., CN Leiden, The Netherlands
| | | | - Gerard Scheppink
- Janssen Vaccines and Prevention B.V., CN Leiden, The Netherlands
| | - Bojana Pajic
- Janssen Vaccines and Prevention B.V., CN Leiden, The Netherlands
| | - Justin Dudink
- Janssen Vaccines and Prevention B.V., CN Leiden, The Netherlands
| | - Cari Sänger-van de Griend
- Janssen Vaccines and Prevention B.V., CN Leiden, The Netherlands.,Department of Medicinal Chemistry, Faculty of Pharmacy, Biomedical Centre, Uppsala University, Uppsala, Sweden.,Kantisto B.V., Baarn, The Netherlands
| |
Collapse
|
10
|
Rustandi RR, Hamm M. Development of an ADP-ribosylation assay for residual toxicity in C. difficile binary toxin CDTa using automated capillary western blot. J Pharm Biomed Anal 2020; 182:113125. [DOI: 10.1016/j.jpba.2020.113125] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2019] [Revised: 01/16/2020] [Accepted: 01/22/2020] [Indexed: 01/05/2023]
|
11
|
Arvin NE, Dawod M, Lamb DT, Anderson JP, Furtaw MD, Kennedy RT. Fast Immunoassay for Microfluidic Western Blotting by Direct Deposition of Reagents onto Capture Membrane. ANALYTICAL METHODS : ADVANCING METHODS AND APPLICATIONS 2020; 12:1606-1616. [PMID: 32661464 PMCID: PMC7357712 DOI: 10.1039/d0ay00207k] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/10/2023]
Abstract
Western blotting is a widely used protein assay platform, but the technique requires long analysis times and multiple manual steps. Microfluidic systems are currently being explored for increased automation and reduction of analysis times, sample volumes, and reagent consumption for western blots. Previous work has demonstrated that proteins separated by microchip electrophoresis can be captured on membranes by dragging the microchip outlet across the membrane. This process reduces the separation and transfer time of a western blot to a few minutes. To further improve the speed and miniaturization of a complete western blot, a microscale immunoassay with direct deposition of immunoassay reagents has been developed. Flow deposition of antibodies is used to overcome diffusion limited binding kinetics so that the entire immunoassay can be completed in 1 h with detection sensitivity comparable to incubation steps requiring 20 h. The use of low microliter/min flow rates with antibody reagents applied directly and locally to the membrane where the target proteins have been captured, reduced antibody consumption ~30-fold. The complete western blot was applied to the detection of GAPDH and β-Tubulin from A431 cell lysate.
Collapse
Affiliation(s)
- Natalie E. Arvin
- Department of Chemistry, University of Michigan, 930 N. University Ave., Ann Arbor, Michigan 48109, United States
| | - Mohamed Dawod
- Department of Chemistry, University of Michigan, 930 N. University Ave., Ann Arbor, Michigan 48109, United States
- Vaccine Analytical R&D, Merck Research Laboratories, 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States
| | - Don T. Lamb
- LI-COR Biosciences, 4647 Superior St., Lincoln, Nebraska 68504, United States
| | - Jon P. Anderson
- LI-COR Biosciences, 4647 Superior St., Lincoln, Nebraska 68504, United States
| | - Michael D. Furtaw
- LI-COR Biosciences, 4647 Superior St., Lincoln, Nebraska 68504, United States
| | - Robert T. Kennedy
- Department of Chemistry, University of Michigan, 930 N. University Ave., Ann Arbor, Michigan 48109, United States
- Department of Pharmacology, University of Michigan, 1150 W. Medical Center Dr., Ann Arbor, Michigan 48109, United States
- Corresponding author: Robert T. Kennedy, , Tel: 734-615-4363, Fax: 745-615-6462
| |
Collapse
|
12
|
Zhu Y, Ahluwalia D, Chen Y, Belakavadi M, Katiyar A, Das TK. Characterization of therapeutic antibody fragmentation using automated capillary western blotting as an orthogonal analytical technique. Electrophoresis 2019; 40:2888-2898. [PMID: 31271455 DOI: 10.1002/elps.201900119] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2019] [Revised: 06/14/2019] [Accepted: 06/25/2019] [Indexed: 11/06/2022]
Abstract
Fragmentation in protein-based molecules continues to be a challenge during manufacturing and storage, and requires an appropriate control strategy to ensure purity and integrity of the drug product. Electrophoretic and chromatographic methods are commonly used for monitoring the fragments. However, size-exclusion chromatography often suffers from low resolution of low molecular weight fragments. Electrophoretic methods like CE-SDS are not compatible with enriching fragments for additional characterization tests such as MS. These limitations may result in inadequate control strategy for monitoring and characterizing fragments for protein-based molecules. Capillary western blotting was used in this study as an orthogonal method for characterization of fragments in an IgG1 antibody under reduced conditions. To achieve a comprehensive mapping of various fragments generated by thermal stress, capillary western profiles were generated using recognition antibodies for IgG kappa (κ) light chain, Fc, and Fab regions that enabled unambiguous fragment identification. Additionally, three different enzymatic digestion methods (IdeS, PNGase F, and IgdE) were applied coupled with capillary western blotting for clip identifications. Finally, complementary data collected using traditional chromatographic and electrophoretic methods allowed to establish a comparison of analytical profiles with an added benefit of fragment identification offered by capillary western profiling. In addition to various Fc and Fab-related low molecular weight fragments, a non-reducible thio-ether linked 75 kDa HL fragment was also identified.
Collapse
Affiliation(s)
- Yunxiao Zhu
- Methods and Analytical Development, Bristol-Myers Squibb, Pennington, NJ, USA
| | - Deepti Ahluwalia
- Methods and Analytical Development, Bristol-Myers Squibb, Pennington, NJ, USA
| | - Yingchen Chen
- Methods and Analytical Development, Bristol-Myers Squibb, Pennington, NJ, USA
| | - Madesh Belakavadi
- Methods and Analytical Development, Bristol-Myers Squibb, Pennington, NJ, USA
| | - Amit Katiyar
- Methods and Analytical Development, Bristol-Myers Squibb, Pennington, NJ, USA.,Analytical and Formulation Sciences, Patheon, Thermo Fisher Scientific, Princeton, NJ, USA
| | - Tapan K Das
- Methods and Analytical Development, Bristol-Myers Squibb, Pennington, NJ, USA
| |
Collapse
|
13
|
Desharnais P, Naud J, Ayotte C. Detection of erythropoiesis stimulating agents in urine samples using a capillary Western system. Drug Test Anal 2018; 10:1698-1707. [DOI: 10.1002/dta.2528] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2018] [Revised: 10/16/2018] [Accepted: 10/16/2018] [Indexed: 11/09/2022]
Affiliation(s)
- Philippe Desharnais
- Laboratoire de contrôle du dopageINRS‐Institut Armand‐Frappier 531 Boulevard des Prairies Laval (Québec) Canada H7V1B7
| | - Jean‐François Naud
- Laboratoire de contrôle du dopageINRS‐Institut Armand‐Frappier 531 Boulevard des Prairies Laval (Québec) Canada H7V1B7
| | - Christiane Ayotte
- Laboratoire de contrôle du dopageINRS‐Institut Armand‐Frappier 531 Boulevard des Prairies Laval (Québec) Canada H7V1B7
| |
Collapse
|
14
|
Hall CL, Wells AR, Leung KP. Pirfenidone reduces profibrotic responses in human dermal myofibroblasts, in vitro. J Transl Med 2018; 98:640-655. [PMID: 29497173 DOI: 10.1038/s41374-017-0014-3] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2017] [Revised: 11/15/2017] [Accepted: 12/10/2017] [Indexed: 12/11/2022] Open
Abstract
Pirfenidone (PFD) is a synthetic small molecule inhibitor with demonstrated anti-inflammatory and antifibrotic properties in vitro and in vivo. The exact mechanism(s) of PFD action remain unclear, due in part to the broad effects of this drug on the complex processes involved in inflammation and fibrosis. While PFD is FDA-approved for the treatment of idiopathic pulmonary fibrosis, the efficacy of this compound for the treatment of dermal fibrosis has not yet been fully characterized. Dermal fibrosis is the pathological formation of excess fibrous connective tissue of the skin, usually the result of traumatic cutaneous injury. Fibroproliferative scarring, caused by delayed wound healing and prolonged inflammation, remains a major clinical concern with considerable morbidity. Despite efforts to identify a therapeutic that targets the fibrotic pathways involved in wound healing to mitigate scar formation, no satisfactory dermal antifibrotic has yet been identified. We aim to better elucidate the antifibrotic mechanism(s) of PFD activity using an in vitro model of dermal fibrosis. Briefly, cultured human dermal fibroblasts were stimulated with TGF-β1 to induce differentiation into profibrotic myofibroblast cells. A dose-dependent reduction in cellular proliferation and migration was observed in TGF-β1-stimulated cells when treated with PFD. We observed a clear inhibition in the development of essential myofibroblast mechanoregulatory machinery, including contractile F-actin stress fibers containing α-SMA and large super-mature focal adhesions. PFD treatment significantly reduced protein levels of major ECM components type I and type III collagen. PFD targeted the p38 MAPK signaling pathway and mitigated profibrotic gene expression profiles. This in vitro data promotes PFD as a potential therapeutic agent for the treatment of dermal fibrosis.
Collapse
Affiliation(s)
- Caroline L Hall
- Dental and Craniofacial Trauma and Tissue Regeneration Directorate, United States Army Institute of Surgical Research, 3698 Chambers Pass, Building 3610, Joint Base San Antonio/Fort Sam Houston, TX, 78234, USA
| | - Adrienne R Wells
- Dental and Craniofacial Trauma and Tissue Regeneration Directorate, United States Army Institute of Surgical Research, 3698 Chambers Pass, Building 3610, Joint Base San Antonio/Fort Sam Houston, TX, 78234, USA
| | - Kai P Leung
- Dental and Craniofacial Trauma and Tissue Regeneration Directorate, United States Army Institute of Surgical Research, 3698 Chambers Pass, Building 3610, Joint Base San Antonio/Fort Sam Houston, TX, 78234, USA.
| |
Collapse
|
15
|
Mishra M, Tiwari S, Gomes AV. Protein purification and analysis: next generation Western blotting techniques. Expert Rev Proteomics 2017; 14:1037-1053. [PMID: 28974114 DOI: 10.1080/14789450.2017.1388167] [Citation(s) in RCA: 129] [Impact Index Per Article: 18.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
INTRODUCTION Western blotting is one of the most commonly used techniques in molecular biology and proteomics. Since western blotting is a multistep protocol, variations and errors can occur at any step reducing the reliability and reproducibility of this technique. Recent reports suggest that a few key steps, such as the sample preparation method, the amount and source of primary antibody used, as well as the normalization method utilized, are critical for reproducible western blot results. Areas covered: In this review, improvements in different areas of western blotting, including protein transfer and antibody validation, are summarized. The review discusses the most advanced western blotting techniques available and highlights the relationship between next generation western blotting techniques and its clinical relevance. Expert commentary: Over the last decade significant improvements have been made in creating more sensitive, automated, and advanced techniques by optimizing various aspects of the western blot protocol. New methods such as single cell-resolution western blot, capillary electrophoresis, DigiWest, automated microfluid western blotting and microchip electrophoresis have all been developed to reduce potential problems associated with the western blotting technique. Innovative developments in instrumentation and increased sensitivity for western blots offer novel possibilities for increasing the clinical implications of western blot.
Collapse
Affiliation(s)
- Manish Mishra
- a Department of Physiology , University of Saskatchewan College of Medicine , Saskatoon , SK , Canada
| | - Shuchita Tiwari
- b Department of Neurobiology, Physiology, and Behavior , University of California , Davis , CA , USA
| | - Aldrin V Gomes
- b Department of Neurobiology, Physiology, and Behavior , University of California , Davis , CA , USA.,c Department of Physiology and Membrane Biology , University of California , Davis , CA , USA
| |
Collapse
|
16
|
Quantitation of CRM197 using imaged capillary isoelectric focusing with fluorescence detection and capillary Western. Anal Biochem 2017; 534:19-23. [DOI: 10.1016/j.ab.2017.06.013] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2017] [Revised: 05/31/2017] [Accepted: 06/26/2017] [Indexed: 12/14/2022]
|
17
|
Quantitative analysis of a biopharmaceutical protein in cell culture samples using automated capillary electrophoresis (CE) western blot. J Pharm Biomed Anal 2017. [DOI: 10.1016/j.jpba.2017.06.025] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
18
|
Abstract
Proteomics encompasses a variety of approaches unraveling both the structural features, post-translational modifications, and abundance of proteins. As of today, proteomic studies have shed light on the primary structure of about 850 allergens, enabling the design of microarrays for improved molecular diagnosis. Proteomic methods including mass spectrometry allow as well to investigate protein-protein interactions, thus yielding precise information on critical epitopes on the surface of allergens. Mass spectrometry is now being applied to the unambiguous identification, characterization, and comprehensive quantification of allergens in a variety of matrices, as diverse as food samples and allergen immunotherapy drug products. As such, it represents a method of choice for quality testing of allergen immunotherapy products.
Collapse
|
19
|
Wang J, Valdez A, Chen Y. Evaluation of automated Wes system as an analytical and characterization tool to support monoclonal antibody drug product development. J Pharm Biomed Anal 2017; 139:263-268. [DOI: 10.1016/j.jpba.2016.12.024] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2016] [Revised: 12/07/2016] [Accepted: 12/17/2016] [Indexed: 10/20/2022]
|
20
|
Yeh HY, Serrano KV, Acosta AS, Buhr RJ. Production of recombinant Salmonella flagellar protein, FlgK, and its uses in detection of anti-Salmonella antibodies in chickens by automated capillary immunoassay. J Microbiol Methods 2016; 122:27-32. [PMID: 26784737 DOI: 10.1016/j.mimet.2016.01.007] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2015] [Revised: 01/13/2016] [Accepted: 01/14/2016] [Indexed: 11/27/2022]
Abstract
Conventional immunoblot assays are a useful tool for specific protein identification, but tedious, labor-intensive and time-consuming. A capillary electrophoresis-based immunoblot assay so-called "Simple Western" was developed to enable the protein identification in an automatic manner. This communication describes the use of Simple Western for detecting anti-Salmonella FlgK antibodies from chicken sera.
Collapse
Affiliation(s)
- Hung-Yueh Yeh
- United States Department of Agriculture, Agricultural Research Service, U.S. National Poultry Research Center, Poultry Microbiological Safety and Processing Research Unit, 950 College Station Road, Athens, GA 30605-2720, USA.
| | - Katherine Vargas Serrano
- Food Science and Technology Program, Faculty of Agricultural Sciences, University of Puerto Rico Mayagüez Campus, P.O. Box 9000, Mayagüez, PR 00681-9000, USA
| | - Aimee Silvestry Acosta
- Food Science and Technology Program, Faculty of Agricultural Sciences, University of Puerto Rico Mayagüez Campus, P.O. Box 9000, Mayagüez, PR 00681-9000, USA
| | - Richard J Buhr
- United States Department of Agriculture, Agricultural Research Service, U.S. National Poultry Research Center, Poultry Microbiological Safety and Processing Research Unit, 950 College Station Road, Athens, GA 30605-2720, USA
| |
Collapse
|
21
|
Rustandi RR, Hamm M, Lancaster C, Loughney JW. Applications of an Automated and Quantitative CE-Based Size and Charge Western Blot for Therapeutic Proteins and Vaccines. Methods Mol Biol 2016; 1466:197-217. [PMID: 27473492 DOI: 10.1007/978-1-4939-4014-1_16] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
Capillary Electrophoresis (CE) is a versatile and indispensable analytical tool that can be applied to characterize proteins. In recent years, labor-intensive SDS-PAGE and IEF slab gels have been replaced with CE-SDS (CGE) and CE-IEF methods, respectively, in the biopharmaceutical industry. These two CE-based methods are now an industry standard and are an expectation of the regulatory agencies for biologics characterization. Another important and traditional slab gel technique is the western blot, which detects proteins using immuno-specific reagents after SDS-PAGE separation. This technique is widely used across industrial and academic laboratories, but it is very laborious, manual, time-consuming, and only semi-quantitative. Here, we describe the applications of a relatively new CE-based western blot technology which is automated, fast, and quantitative. We have used this technology for both charge- and size-based CE westerns to analyze biotherapeutic and vaccine products. The size-based capillary western can be used for fast antibody screening, clone selection, product titer, identity, and degradation while the charge-based capillary western can be used to study product charge heterogeneity. Examples using this technology for monoclonal antibody (mAb), Enbrel, CRM197, and Clostridium difficile (C. difficile) vaccine proteins are presented here to demonstrate the utility of the capillary western techniques. Details of sample preparation and experimental conditions for each capillary western mode are described in this chapter.
Collapse
Affiliation(s)
- Richard R Rustandi
- Merck Research Laboratories, Vaccine Analytical Development, 770 Sumneytown Pike, WP42A-30, P.O. Box 4, West Point, PA, 19486, USA.
| | - Melissa Hamm
- Merck Research Laboratories, Vaccine Analytical Development, 770 Sumneytown Pike, WP42A-30, P.O. Box 4, West Point, PA, 19486, USA
| | - Catherine Lancaster
- Merck Research Laboratories, Vaccine Analytical Development, 770 Sumneytown Pike, WP42A-30, P.O. Box 4, West Point, PA, 19486, USA
| | - John W Loughney
- Merck Research Laboratories, Vaccine Analytical Development, 770 Sumneytown Pike, WP42A-30, P.O. Box 4, West Point, PA, 19486, USA
| |
Collapse
|
22
|
Rustandi RR, Hamm M, Loughney JW, Ha S. Detection of ADP ribosylation in PARP-1 and bacterial toxins using a capillary-based western system. Electrophoresis 2015; 36:2798-2804. [DOI: 10.1002/elps.201500173] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2015] [Revised: 05/26/2015] [Accepted: 05/27/2015] [Indexed: 11/10/2022]
Affiliation(s)
| | - Melissa Hamm
- Vaccine Analytical Development; Merck Research Laboratories; PA USA
| | - John W. Loughney
- Vaccine Analytical Development; Merck Research Laboratories; PA USA
| | - Sha Ha
- Vaccine Analytical Development; Merck Research Laboratories; PA USA
| |
Collapse
|